INGELHEIM, Germany & BALTIMORE, Md.--(BUSINESS WIRE)--Boehringer Ingelheim and the Lieber Institute for Brain Development (LIBD) today announced a joint research and licensing collaboration focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results